BriaCell Therapeutics Corp.

04/27/2026

BriaCell (Nasdaq: BCTX, BCTXL) (TSX: BCT) announced three clinical data poster presentations and three publication-only abstracts at the 2026 ASCO Annual Meeting, taking place May 29 - June 2, 2026 at McCormick Place, Chicago, Illinois.

For poster presentation sessions and publish-only abstract details, please visit: https://bit.ly/48KhoCj

04/22/2026

Immune cells activated by BriaCell's Bria-OTS+™ platform demonstrated serial killing activity across multiple rounds of tumor cell challenge — with broad anti-tumor activity against multiple tumor targets, limited induction of immunosuppressive cell populations, and durable cytokine responses. BriaCell plans to advance Bria-OTS+ toward the clinic for metastatic breast cancer and prostate cancer later this year. Read more: https://bit.ly/4thRyh0

04/22/2026

BriaCell's Phase 2 data presentations at identify potential prognostic biomarkers in metastatic breast cancer, including mitotic circulating tumor cells as a novel biomarker and PD-L1 expression in tumor-macrophage fusion cells as a real-time indicator of immune checkpoint inhibitor response. Learn more: https://bit.ly/4cmBJjh

04/21/2026

Saranya Chumsri, MD, Principal Investigator of BriaCell's Phase 3 study of Bria-IMT+CPI, and Professor of Oncology, Mayo Clinic, highlights the Company's quality of life data presented at the 2026 AACR Annual Meeting. Read more: https://bit.ly/4cmBJjh

04/21/2026

BriaCell Chief Scientific Officer, Miguel A. Lopez-Lago, PhD, comments on the Company's positive preclinical Bria-OTS+™ data being presented at the 2026 AACR Annual Meeting, highlighting early, strong, and long-lasting anti-cancer activity across multiple cancer models. Learn more: https://bit.ly/4thRyh0

04/21/2026

BriaCell (Nasdaq: BCTX, BCTXL) (TSX: BCT) is presenting positive data from its preclinical Bria-OTS+™ platform at the 2026 American Association for Cancer Research (AACR) Annual Meeting at the San Diego Convention Center in San Diego, California.

Results demonstrate that Bria-OTS+ provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line models. Find details: https://bit.ly/4thRyh0

04/20/2026

Heavily pretreated metastatic breast cancer patients in BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune checkpoint inhibitor maintained overall health status and key functional measures with a favorable safety profile — showing quality of life largely preserved in patients with prior ADC, CPI, and CDK4/6 inhibitor exposure. Read more: https://bit.ly/4cmBJjh

04/20/2026

BriaCell President & CEO Dr. William V. Williams commented on the Company's new quality of life data from the Phase 3 Bria-IMT + CPI study in patients with metastatic breast cancer who failed prior therapies being presented at the 2026 AACR Annual Meeting. Learn more: https://bit.ly/4cmBJjh

04/20/2026

BriaCell (Nasdaq: BCTX, BCTXL) (TSX: BCT) is presenting positive data in three clinical posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22 at the San Diego Convention Center in San Diego, California.

The presentations include one poster featuring data from BriaCell's ongoing pivotal Phase 3 study of Bria-IMT™ plus an immune checkpoint inhibitor, and two posters highlighting further analyses of Phase 2 data. Find details: https://bit.ly/4cmBJjh

04/18/2026

BriaCell is proud to support Living Beyond Breast Cancer's Thriving Together: 2026 Conference on Metastatic Breast Cancer taking place, April 17–19 in Philadelphia, with a livestream option available.

Now in its 20th year, this conference brings together people living with metastatic breast cancer, caregivers, and experts from across the country for a weekend to connect with others who understand, learn from trusted experts, and find support to thrive — together.

To learn more and register, visit: lbbc.org/26metsconf

In its 20th year, this conference brings together people living with MBC, caregivers, and experts for a weekend centered on real answers, real stories, and real help.

04/16/2026

We’re proud to support Living Beyond Breast Cancer’s Thriving Together: 2026 Conference on Metastatic Breast Cancer.

This conference is trusted because it brings together leading medical experts and people living with metastatic breast cancer — honoring lived experience as expertise. It’s an essential space for connection, education, and community.

April 17–19 | Philadelphia + Livestream
Learn more and register: lbbc.org/26metsconf

03/30/2026

Join the Mission at BriaCell!

We’re on a journey to change cancer treatment, and we need passionate, curious, and driven people to help us get there. Your ideas, your impact, your future—start here.

https://briacell.com/careers/